tradingkey.logo

Bionano Genomics Inc

BNGO
1.700USD
0.000
收盘 11/04, 16:00美东报价延迟15分钟
6.65M总市值
亏损市盈率 TTM

Bionano Genomics Inc

1.700
0.000

关于 Bionano Genomics Inc 公司

Bionano Genomics, Inc. 是一家基因组学公司。该公司提供光学基因组图谱 (OGM) 解决方案,适用于基础研究、转化研究和临床研究。通过 Lineagen, Inc.,该公司还为临床表现与自闭症谱系障碍和其他神经发育障碍一致的患者提供诊断测试。它还提供与平台无关的软件解决方案,该解决方案集成了测序和微阵列数据,旨在通过一个综合视图提供对整个基因组的拷贝数变异、单核苷酸变异和杂合性缺失的分析、可视化、解释和报告。该公司还使用专有的等速电泳 (ITP) 技术提供核酸提取和纯化解决方案。该公司营销和销售 OGM 系统,包括 Saphyr 系统,该系统提供 OGM 数据,以实现对所有类别的结构变异 (SV) 的超灵敏和超特异性检测。

Bionano Genomics Inc简介

公司代码BNGO
公司名称Bionano Genomics Inc
上市日期Aug 01, 2018
CEODr. R. Erik Holmlin, Ph.D.
员工数量98
证券类型Ordinary Share
年结日Aug 01
公司地址9540 Towne Centre Drive
城市SAN DIEGO
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编92121
电话18588887600
网址https://bionano.com/
公司代码BNGO
上市日期Aug 01, 2018
CEODr. R. Erik Holmlin, Ph.D.

Bionano Genomics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
业务USD
名称
营收
占比
Consumables
3.28M
48.66%
Software
1.64M
24.28%
Instruments
1.40M
20.78%
Services and other
423.00K
6.28%
地区USD
名称
营收
占比
EMEIA
3.23M
47.94%
Americas
2.93M
43.46%
Asia Pacific
579.00K
8.60%
业务
地区
业务USD
名称
营收
占比
Consumables
3.28M
48.66%
Software
1.64M
24.28%
Instruments
1.40M
20.78%
Services and other
423.00K
6.28%

股东统计

更新时间: 10月7日 周二
更新时间: 10月7日 周二
持股股东
股东类型
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
5.42%
The Lind Partners, LLC
4.97%
Heights Capital Management, Inc.
4.91%
Iroquois Capital Management, LLC
3.80%
Abbe (Richard)
1.63%
其他
79.28%
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
5.42%
The Lind Partners, LLC
4.97%
Heights Capital Management, Inc.
4.91%
Iroquois Capital Management, LLC
3.80%
Abbe (Richard)
1.63%
其他
79.28%
股东类型
持股股东
占比
Investment Advisor
10.15%
Corporation
5.42%
Hedge Fund
4.23%
Individual Investor
1.65%
Investment Advisor/Hedge Fund
0.19%
Research Firm
0.12%
其他
78.22%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
131
1.42M
14.71%
+1.17M
2025Q2
193
352.54K
10.48%
-62.70K
2025Q1
262
309.73K
9.24%
-123.47K
2024Q4
284
105.26K
3.91%
-124.97K
2024Q3
298
94.17K
6.55%
-135.04K
2024Q2
310
116.15K
9.81%
-164.95K
2024Q1
318
86.19K
9.42%
-64.99K
2023Q4
324
107.44K
14.24%
-23.70K
2023Q3
345
94.81K
16.11%
-27.58K
2023Q2
356
93.86K
18.29%
-63.50K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Lincoln Alternative Strategies LLC
525.00K
5.42%
+525.00K
--
Sep 17, 2025
The Lind Partners, LLC
480.96K
4.97%
+480.96K
--
Sep 17, 2025
Heights Capital Management, Inc.
475.00K
4.91%
+475.00K
--
Sep 16, 2025
Iroquois Capital Management, LLC
367.50K
3.8%
+367.50K
--
Sep 16, 2025
Abbe (Richard)
157.50K
1.63%
+157.50K
--
Sep 16, 2025
GSA Capital Partners LLP
40.08K
0.41%
+40.08K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
18.87K
0.19%
+3.37K
+21.70%
Jun 30, 2025
Parametric Portfolio Associates LLC
11.00K
0.11%
-484.00
-4.21%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.94K
0.1%
-167.00
-1.65%
Jun 30, 2025
BofA Global Research (US)
8.41K
0.09%
+16.00
+0.19%
Jun 30, 2025
查看更多

持股ETF

更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
公告日期
类型
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI